DRAVET SYNDROME
Clinical trials for DRAVET SYNDROME explained in plain language.
Never miss a new study
Get alerted when new DRAVET SYNDROME trials appear
Sign up with your email to follow new studies for DRAVET SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough gene therapy trial offers hope for children with severe epilepsy
Disease control Recruiting nowThis study is testing a gene therapy called ETX101 for children with Dravet syndrome, a severe form of epilepsy. Researchers are checking if the treatment is safe and if it can reduce seizure frequency and improve development. The trial includes infants as young as 6 months up to…
Matched conditions: DRAVET SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Encoded Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Real-World CBD treatment study for devastating childhood epilepsies
Disease control Recruiting nowThis study observes how well a CBD medication works for people with severe epilepsy syndromes (Lennox-Gastaut, Dravet, or Tuberous Sclerosis Complex) in real-world settings. About 100 children and adults who are already prescribed this CBD treatment by their doctor will be follow…
Matched conditions: DRAVET SYNDROME
Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New drug trial offers hope for controlling severe seizures in rare genetic disorder
Disease control Recruiting nowThis study is testing whether the experimental drug LP352 can safely reduce seizure frequency in people with Dravet syndrome, a rare and severe form of epilepsy. The trial will involve 160 children and adults who will receive either LP352 or a placebo for approximately 24 months.…
Matched conditions: DRAVET SYNDROME
Phase: PHASE3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for kids with severe epilepsy: groundbreaking trial targets root cause
Disease control Recruiting nowThis study is testing an investigational medicine called zorevunersen (STK-001) for children and adolescents with Dravet syndrome, a severe form of epilepsy. The goal is to see if the medicine can safely reduce the number of major seizures and improve behavior, thinking, and qual…
Matched conditions: DRAVET SYNDROME
Phase: PHASE3 • Sponsor: Stoke Therapeutics, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists launch 4-Year quest to map dravet Syndrome's impact on growing minds
Knowledge-focused Recruiting nowThis study aims to better understand how Dravet syndrome, a severe genetic epilepsy, affects development over time. Researchers will follow 50 children and young adults (ages 6 months to 21 years) for four years, tracking their motor skills, thinking abilities, and daily living s…
Matched conditions: DRAVET SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Major study launches to track 1000 children with rare epilepsies
Knowledge-focused Recruiting nowThis study aims to better understand rare childhood epilepsies by following 1000 children and adolescents in real-world settings. Researchers will track how different treatments affect seizure frequency and how thinking skills and mental health change over time. The goal is to ga…
Matched conditions: DRAVET SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC